Nasdaq · Biotech stocks database
ADAG (Adagene Inc.) stock: $2.00, $132.1M market cap, $127.9M cash, $5.3M EV, $178.2M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
We also cannot rule out the possibility that certain of our customers may be deemed as CIIOs, or as operators processing important data, in which case our products or services or data processing activities, if being deemed as related to national security, will need to be submitted for cybersecurity review before we can enter into agreements with such customers, and before the conclusion of such procedure, the customers will not be allowed to use our products or services.
Source: 20-F FY2025 via SEC EDGAR
| Cash | $127.9M |
|---|---|
| Debt | $1.1M |
| Net cash | $126.8M |
| Enterprise value | $5.3M |
| Basic shares | 66.1M shares |
| Fully diluted shares | 89.1M shares |
| Fully diluted market cap | $178.2M |
| Cash per share | $1.94 |
| Quarterly burn | $2.3M |
| Cash runway | 56.5 quarters |
Cash figures as of 2026-06-30. Database snapshot: 2026-11-07.
Cap table as of 2026-06-30.
Loading ADAG daily closes…
muzastotug (ADG126) · Est. Apr 1, 2027 · half midpoint · guided in 8 wks